From Efficacy to Adversity: Understanding the Side Effects of Antidepressants - systematic review
1
Neurology, Neurosurgery and Psychiatry, Uzhhorod National University, Ukraine
2
Urology Department, Mazovia Hospital, Poland
Submission date: 2024-05-06
Final revision date: 2024-09-22
Acceptance date: 2024-12-09
Publication date: 2025-01-31
Wiadomości Lekarskie 2025;(1):187-196
KEYWORDS
TOPICS
ABSTRACT
Introduction: Antidepressants are among the most commonly prescribed medications. Despite the fact that these medications are the third most frequently prescribed and the fourth best-selling. Up to 70% of patients have problems with treatment adherence, one third will stop taking antidepressants within the first month and almost half within the first three months. Side effects is one of the most common cause of antidepressants withdrawal.
The aim: To investigate how and why antidepressant side effects occur, in order to use them effectively in clinical practice
Materials and methods: We have studied modern literary sources on the topic of side effects of antidepressant and presented in the form of a literature review in this article. Electronic Scopus and Pubmed databases were searched for articles on the studied topic. The review included original articles, research, and official recommendations from medical associations.
Conclusions: Side effects of antidepressants can reduce treatment adherence and delay recovery. Therefore, it is extremely important to consider possible side effects when choosing a therapy. While there is no perfect antidepressant that works quickly and is completely free of side effects, newer antidepressants are safer, better tolerated, and associated with lower rates of treatment failure. Most side effects occur as a consequence of the basic mechanism of action of the drugs. Therefore, it is important to understand the neurobiology of side effects, their frequency and risks, ways to prevent them or use them to your advantage resources.
REFERENCES (40)
1.
Olfson M, Blanco C, Wang S et al. National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians, JAMA Psychiatry 2014; 71 (1), 81-90. DOI: 10.1001/jamapsychiatry.2013.3074.
2.
Mojtabai R, Olfson M, Han B. National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults. Pediatrics 2016; 138 (6). DOI: 10.1542/peds.2016-1878.
3.
Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States,2005-2008. NCHS Data Brief. 2011;(76):1-8.
4.
Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. BMJ. 2005 Jul 16; 331(7509): 155–157. doi: 10.1136/bmj.331.7509.155.
5.
Stephen M. Stahl. Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Applications, 4th Edition. University of California, San Diego. April 2013 (p. 286).
6.
Cipriani A , Furukawa T , Salanti G. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. Lancet 2018; 391 (10128), 1357-1366. DOI: 10.1016/S0140-6736(17)32802-7.
7.
Zajecka JM. Clinical issues in long term treatment with antidepressants. J Clin Psychiatry 2000; 61(suppl l2):20–25.
8.
Kuhn R. The imipramine story. Ayd F editor. Philadelphia: JB Lippincott; 1970.p. 205-17.
9.
Glowinski J, Axelrod J. Inhibition of uptake of triated noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 1964;204:1318–9.
10.
Trindade E, Menon D, Topfer LA, et al. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 1998;159:1245–52.
11.
Richelson E. Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance. J Clin Psychiatry. 2003;64 Suppl 13:5-12.
12.
Taciak P, Lysenko N, Mazurek PA, Drugs which influence serotonin transporter and serotonergic receptors: pharmacological and clinical properties in the treatment of depression (2010), http://dx.doi.org/10.1016/j.ph....
13.
Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol Ther 2013;137:119–31.
14.
Rosenzweig-Lipson S, Beyer CE, Hughes ZA, et al. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther 2007;113:134–53.
16.
Kovac AL. Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT3 ReceptorAntagonists for Postoperative Nausea and Vomiting. Drugs 2016;76:1719–35.
17.
Greist J, McNamara RK, Mallinckrodt CH, et al. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine. Clin Ther 2004;26:1446–55.
18.
Wysokinski A, Kloszewska I. Mechanisms of increased appetite and weight gain induced by psychotropic medications. J Adv Clin Pharmacol 2014;1: 12–33.
19.
Uguz F, Sahingoz M, Gungor B, et al. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry.
20.
Kivimaki M, Hamer M, Batty GD, et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care 2010;33:2611–6.
21.
Himmerich H, Schuld A, Haack M, et al. Early prediction of changes in weight during six weeks of treatment with antidepressants. J Psychiatr Res 2004;38:485–9.
22.
Safer DL et al. Use of Mirtazapine in an Adult With Refractory Anorexia Nervosa and Comorbid Depression: A Case Report Int J Eat Disord 44 (2), 178-81. Mar 2011. PMID 20127940.
23.
Couturier J et al. A Review of Medication Use for Children and Adolescents With Eating Disorders. J Can Acad Child Adolesc Psychiatry 16 (4), 173-6. Nov 2007. PMID 18392170.
24.
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990;19:389–408.
25.
Graf H, Walter M, Metzger CD, et al. Antidepressant-related sexual dysfunction – perspectives from neuroimaging. Pharmacol Biochem Behav, 2014;121:138–45.
26.
Chan JS, Olivier B, de Jong TR, et al. Translational research into sexual disorders: pharmacology and genomics. Eur J Pharmacol 2008;585:426–35.
27.
Briki M, Haffen E, Sechter D, et al. Effets sur la libido. In: Corruble E, editor. Les Antidépresseurs. Médecine Sciences Publications/Lavoisier; 2013. p. 219–28.
28.
Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999;19:67–85.
29.
Kennedy SH, Lam RW, Nutt J, Thase ME. Treating Depression Effectively. 2nd ed. Oxfordshire, UK: Informa Healthcare; 2007.
30.
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants. A meta-analysis. J Clin Psychopharmacol 2009;29:259–66.
31.
Stryjer R, Spivak B, Strous R D et al. Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors: A Preliminary Open-Label Study. Clinical neuropharmacology 32(2):82-4, Mar-Apr 2009.
32.
Waldinger MD. The neurobiological approach to premature ejaculation.J.Urol.2002;168: 2359–67.
33.
Taylor D et al. Antidepressant efficacy of agomelatine: Meta-analysis of published and unpublished studies. BMJ 2014 Mar 19. doi:10.1136/bmj.g1888.
34.
Орос ММ, Орос СВ, Смоланка ВІ, Іваньо ТВ. Депресія та інсомнія: виявлення причинно-наслідкових зв'язків з метою вибору тактики лікування. "Міжнародний неврологічний журнал" 2017, 7 (93). DOI: 10.22141/2224-0713.7.93.2017.116550.
35.
Kahl, K. G. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Hormone Molecular Biology and Clinical Investigation 2018.
36.
Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998;59(10):502–508. doi:10.4088/jcp.v59n1002.
37.
de Abajo FJ, García-Rodríguez LA. Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy: Interaction With Nonsteroidal Anti-inflammatory Drugs and Effect of Acid-Suppressing Agents. Arch Gen Psychiatry. 2008;65(7):795–803. doi:10.1001/archpsyc.65.7.795.
38.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychother Psychosom. 2016;85(5):270–288. doi:10.1159/000447034.
39.
Goldberg JF, Ernst CL, Managing the side effects of psychotropic medications. 1st ed. American Psychiatric Publishing. Washington, DC: American Psychiatric Pub; 2012.
40.
Planes S, Villier C, Mallaret M. The nocebo effect of drugs. Pharmacol Res Perspect 2016;4:e00208.
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
